Key result
Colforsin increased cardiac output compared to baseline in both normal and acidosis conditions.
Why the study?
In acidosis, catecholamine effects are attenuated, often requiring higher doses to improve cardiovascular function, whereas colforsin activates adenylate cyclase without mediating the beta adrenoceptor.
Does intravenous colforsin improve cardiovascular function compared to dobutamine in normal and acute respiratory acidosis canine models?
RCT (n=6)
Randomized crossover
No
Does intravenous colforsin improve cardiovascular function compared to dobutamine in normal and acute respiratory acidosis canine models?
In a canine model, colforsin induced cardiovascular effects similar to dobutamine without increasing pulmonary artery pressure, though its ability to increase cardiac output during hypercapnia may be offset by endogenous catecholamines.
Answers are grounded in this paper and cite their sources.
Colforsin matches dobutamine's effects in canine acidosis models but both attenuate; leaves open human translation.
In acidosis, catecholamines are attenuated and higher doses are often required to improve cardiovascular function. Colforsin activates adenylate cyclase in cardiomyocytes without mediating the beta adrenoceptor. In this study, six beagles were administered either colforsin or dobutamine four times during eucapnia (partial pressure of arterial carbon dioxide 35-40 mm Hg; normal) and hypercapnia (ibid 90-110 mm Hg; acidosis) conditions. The latter was induced by carbon dioxide inhalation. Anesthesia was induced with propofol and maintained with isoflurane. Cardiovascular function was measured by thermodilution and a Swan-Ganz catheter. Cardiac output, heart rate, and systemic vascular resistance were determined at baseline and 60 min after 0.3 μg/kg/min (low), 0.6 μg/kg/min (middle), and 1.2 μg/kg/min (high) colforsin administration. The median pH was 7.38 [range 7.34–7.42] and 7.04 [range 7.01–7.08] at baseline in the Normal and Acidosis conditions, respectively. Endogenous adrenaline and noradrenaline levels at baseline were significantly ( P < 0.05) higher in the Acidosis than in the Normal condition. Colforsin induced cardiovascular effects similar to those caused by dobutamine. Colforsin increased cardiac output in the Normal condition (baseline: 198.8 mL/kg/min [range 119.6–240.9], low: 210.8 mL/kg/min [range 171.9–362.6], middle: 313.8 mL/kg/min [range 231.2–473.2], high: 441.4 mL/kg/min [range 373.9–509.3]; P < 0.001) and the Acidosis condition (baseline: 285.0 mL/kg/min [range 195.9–355.0], low: 297.4 mL/kg/min [213.3–340.6], middle: 336.3 mL/kg/min [291.3–414.5], high: 366.7 mL/kg/min [339.7–455.7] ml/kg/min; P < 0.001). Colforsin significantly increased heart rate ( P < 0.05 in both conditions) and decreased systemic vascular resistance ( P < 0.05 in both conditions) compared to values at baseline. Systemic vascular resistance was lower in the Acidosis than in the Normal condition ( P < 0.001). Dobutamine increased pulmonary artery pressure, whereas colforsin did not. Colforsin offsets the effects of endogenous catecholamines and may not increase cardiac output during hypercapnia.
No takes yet. Share an insight, caveat, or question.
ITAMI et al. (2019) conducted an RCT in Acute respiratory acidosis (n=6). Colforsin vs. Baseline was evaluated on Cardiac output (Normal condition, high dose vs baseline) (p=<0.001). Colforsin increased cardiac output compared to baseline in both normal and acidosis conditions.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: